We accelerate early-stage digital health and health-tech companies by leveraging top Southeastern European talent and providing strategic access to Western healthcare markets — first investment, then the introductions.
{{ point.body }}
Regional talent, Western markets.
The region trains world-class engineers and clinicians, but almost no early-stage capital reaches them. We write the first investment, then bring the diligence, mentorship and Western market access that turn regional teams into global companies.
Decades in biotech, digital health and venture capital across the partner team, plus 20+ advisors — from Harvard, Imperial, Apple and IBM — who run diligence with us and stay on as mentors.
Based in Manchester, MA, we connect regional innovation to the US and EU healthcare systems actually buying it.
A large, successful Southeastern European diaspora in the US and Europe that mentors founders, opens doors and co-invests.
Pre-seed to Series A in digital health and health tech, anywhere in Southeastern Europe. No specific deck format required — cover vision, business model and growth potential. If four of the five are there, send it.
At least one founder who has worked inside healthcare — a clinician, an operator, or an engineer who has shipped regulated software.
Software, AI or data that gets cheaper to deliver as it grows.
AI care, telemedicine, remote monitoring and provider software — not drug discovery or devices.
A real cost, utilization or care problem — and you can name the buyer and the budget it comes from.
The regional cost base turns the same round into a materially longer runway.
The full version of these five, plus what happens after you send the deck and what you get from us besides capital.
Hospitals and payers in the EU and US are under pressure to cut cost per patient, and the budget is moving to telemedicine, remote monitoring and clinical AI. That software has to be written by someone.
Southeastern Europe already trains the engineers and clinicians who build it for Western companies. We fund them to build it for themselves.
Digital health in the region sits where Western Europe sat a decade ago — while the EU and the US are actively buying cost-reducing care technology.
A strong tradition in medical sciences, engineering and IT. Startups run at a fraction of Silicon Valley cost, so every round buys a longer runway.
Lower entry valuations than Western Europe or the US, government and EU grants and tax incentives, and few local funds bidding — with syndication open to international investors.
The region has already produced globally scaled technology companies, and many Southeastern European startups have expanded West — the path from here to global markets is proven.
No warm intro, no committee, no black box. One partner reads what you send and stays with it to the end — and whichever way it goes, you get an answer and the reason behind it.
Five fields and your deck, in any format. No cover letter, no warm intro required.
Thirty minutes on product, market and team. One partner, no panel.
Diligence with our advisor bench, a term sheet, then mentors, board members and introductions to Western buyers.
Send your deck
EvoMed Consulting
Whether you're a startup, an investor or an industry partner, we invite you to be part of this journey. Send us your deck — we answer either way.